Literature DB >> 23183919

Two novel hydroperoxylated products of 20(S)-protopanaxadiol produced by Mucor racemosus and their cytotoxic activities against human prostate cancer cells.

Guangtong Chen1, Xue Yang, Shaojun Nong, Min Yang, Bohui Xu, Wei Zhang.   

Abstract

Microbial transformation of 20(S)-protopanaxadiol (1) by Mucor racemosus AS 3.205 yielded two novel hydroperoxylated metabolites and three known hydroxylated metabolites. The structures of the metabolites were identified as 26-hydroxyl-20(S)-protopanaxadiol (2), 23,24-en-25-hydroxyl-20(S)-protopanaxadiol (3), 25,26-en-24(R)-hydroperoxyl-20(S)-protopanaxadiol (4), 23,24-en-25-hydroperoxyl-20(S)-protopanaxadiol (5), and 25-hydroxyl-20(S)-protopanaxadiol (6). 4 and 5 are new compounds. Metabolites 2, 4, and 5 showed the more potent inhibitory effects against DU-145 and PC-3 cell lines than the substrate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183919     DOI: 10.1007/s10529-012-1098-x

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  2 in total

1.  20S-dihydroprotopanaxadiol, a ginsenoside derivative, boosts innate immune responses of monocytes and macrophages.

Authors:  Mi-Yeon Kim; Jae Youl Cho
Journal:  J Ginseng Res       Date:  2013-07       Impact factor: 6.060

2.  Proteomic and Metabolomic Analyses Reveal Contrasting Anti-Inflammatory Effects of an Extract of Mucor Racemosus Secondary Metabolites Compared to Dexamethasone.

Authors:  Samuel M Meier; Besnik Muqaku; Ronald Ullmann; Andrea Bileck; Dominique Kreutz; Johanna C Mader; Siegfried Knasmüller; Christopher Gerner
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.